Posterior reversible encephalopathy syndrome in children: Its high prevalence and more extensive imaging findings

被引:77
作者
Ishikura, Kenji
Ikeda, Masahiro
Hamasaki, Yuko
Hataya, Hiroshi
Shishido, Seiichirou
Asanuma, Hiroshi
Nishimura, Gen
Hiramoto, Ryugo
Honda, Masataka
机构
[1] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Pediat Nephrol, Tokyo, Japan
[2] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Pediat Urol & Kidney Transplant, Tokyo, Japan
[3] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Tokyo, Japan
[4] Tokyo Metropolitan Hachioji Childrens Hosp, Dept Pediat Nephrol, Tokyo, Japan
[5] Matsudo City Hosp, Dept Pediat, Chiba, Japan
关键词
posterior reversible encephalopathy syndrome; calcineurin inhibitor; hypertension; pediatric patient; kidney transplantation; kidney disease;
D O I
10.1053/j.ajkd.2006.04.076
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Posterior reversible encephalopathy syndrome is a distinctive clinicoradiological entity observed in a variety of clinical settings, including pediatric patients. A greater prevalence of this syndrome has been suggested in kidney transplant recipients and patients with kidney disease. Although usually considered benign and reversible, characteristics of this syndrome in pediatric patients remain obscure. The objective of the present study involved disclosing details of imaging findings, as well as the clinical course and prevalence of the syndrome in this field. Methods: We investigated kidney transplant recipients and pediatric patients with kidney disease in our institution from 1990 to 2004. For these patients, clinical course, imaging findings, blood pressure, concurrent medical illnesses, and administrative condition of calcineurin inhibitors were analyzed. Results: Twenty cases of posterior reversible encephalopathy syndrome were investigated in patients ranging in age from 1.9 to 18.3 years. In most patients, radiological abnormalities extended to the gray matter (17 of 20 patients), frontal and temporal lobes, and even the cerebellum (16 patients). Of 177 kidney transplant recipients (cyclosporine, 127 patients; tacrolimus, 50 patients), 6 patients administered cyclosporine (4.7%) and 4 patients administered tacrolimus (8.0%) developed the syndrome after transplantation. Conclusion: Posterior reversible encephalopathy syndrome should be suspected in pediatric kidney transplant recipients and patients with kidney disease if they have a sudden episode of neurological symptoms, even if imaging findings are not restricted to the subcortical white matter of the occipital region.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 27 条
[1]   Reversible posterior leukoencephalopathy syndrome [J].
Abe, K .
INTERNAL MEDICINE, 2004, 43 (10) :900-901
[2]   Posterior leukoencephalopathy and nephrotic syndrome: Just a coincidence? [J].
Aksoy, DY ;
Arici, M ;
Kiykim, AA ;
Durusu, M ;
Sahin, G ;
Baydar, DE ;
Altun, B ;
Erdem, Y ;
Yasavul, U ;
Turgan, C ;
Caglar, S .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 327 (03) :156-159
[3]   Neurotoxicity of calcineurin inhibitors: impact and clinical management [J].
Bechstein, WO .
TRANSPLANT INTERNATIONAL, 2000, 13 (05) :313-326
[4]  
Casey SO, 2000, AM J NEURORADIOL, V21, P243
[5]  
Casey SO, 2000, AM J NEURORADIOL, V21, P1199
[6]   Reversible encephalopathy syndrome: report of 12 cases with follow-up [J].
Crasto, SG ;
Rizzo, L ;
Sardo, P ;
Davini, O ;
De Lucchi, R .
NEURORADIOLOGY, 2004, 46 (10) :795-804
[7]  
Dillon WP, 1998, AM J NEURORADIOL, V19, P591
[8]   A reversible posterior leukoencephalopathy syndrome [J].
Hinchey, J ;
Chaves, C ;
Appignani, B ;
Breen, J ;
Pao, L ;
Wang, A ;
Pessin, MS ;
Lamy, C ;
Mas, JL ;
Caplan, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500
[9]   Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome [J].
Ikeda, M ;
Ito, S ;
Hataya, H ;
Honda, M ;
Anbo, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04)
[10]   Posterior leukoencephalopathy syndrome in pediatric patients with kidney disease [J].
Ikeda, M ;
Yata, N ;
Kamei, K ;
Mori, K ;
Ishikura, K ;
Hataya, H ;
Honda, M ;
Asanuma, H ;
Shishido, S ;
Nakai, H .
PEDIATRIC NEPHROLOGY, 2002, 17 (01) :71-71